Veroscience Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VEROSCIENCE, and when can generic versions of VEROSCIENCE drugs launch?
VEROSCIENCE has one approved drug.
There are twelve US patents protecting VEROSCIENCE drugs.
There are thirty-two patent family members on VEROSCIENCE drugs in thirteen countries.
Drugs and US Patents for Veroscience
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,352,025 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 10,688,155 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,192,576 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 10,688,094 | ⤷ Sign Up | ⤷ Sign Up | ||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,613,947 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,877,708 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Veroscience
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,992 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,468,755 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,756,513 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 7,888,310 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,716,957 | ⤷ Sign Up |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,993 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Veroscience Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2682644 | ⤷ Sign Up |
Brazil | 112014027087 | ⤷ Sign Up |
South Korea | 101593360 | ⤷ Sign Up |
Uruguay | 34776 | ⤷ Sign Up |
Japan | 2015515984 | ⤷ Sign Up |
Hong Kong | 1208173 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.